Concepedia

Evrim Gurpinar

EG

6

Publications

942

Citations

6

H-Index

2010

Active since

Affiliations

University of Alabama at Birmingham(Current)

University of South Alabama

USA Mitchell Cancer Institute

Evrim Gurpinar is an author at University of Alabama at Birmingham specializing in medicine, pharmacology, and immunology.

Top concepts

Publications per year

2010–2017

6

Publications

6

Availability of evidence of benefits on overall survival and quality of life of cancer drugs approved by European Medicines Agency: retrospective cohort study of drug approvals 2009-13

Courtney Davis, Huseyin Naci, Evrim Gurpinar et al. · BMJ · 2017 · 575 citations · Full text

Sulindac Selectively Inhibits Colon Tumor Cell Growth by Activating the cGMP/PKG Pathway to Suppress Wnt/β-Catenin Signaling

Nan Li, Yaguang Xi, Heather N. Tinsley et al. · Molecular Cancer Therapeutics · 2013 · 133 citations · Full text

COX-Independent Mechanisms of Cancer Chemoprevention by Anti-Inflammatory Drugs

Evrim Gurpinar, William E. Grizzle, Gary A. Piazza · Frontiers in Oncology · 2013 · 128 citations · Full text

, , +12

Phosphodiesterase 10A is overexpressed in lung tumor cells and inhibitors selectively suppress growth by blocking β-catenin and MAPK signaling

Bing Zhu, Ashley S. Lindsey, Nan Li et al. · Oncotarget · 2017 · 45 citations · Full text

, , +19

A Novel Sulindac Derivative Inhibits Lung Adenocarcinoma Cell Growth through Suppression of Akt/mTOR Signaling and Induction of Autophagy

Evrim Gurpinar, William E. Grizzle, John J. Shacka et al. · Molecular Cancer Therapeutics · 2013 · 39 citations · Full text

Rows per page

1–5 of 6